Effects of melatonin administration and physical exercise during Ramadan diurnal intermittent Fasting on overweight/obesity management
- Disease/Condition
- Nutritional, Metabolic, Endocrine
- Primary sponsor
- Research Laboratory molecular bases of human pathology LR19ES13 Faculty of medicine of Sfax
- Location
- Tunisia
- Phase
- Phase 3
- Start date
- Apr 23, 2020
- End date
- Apr 25, 2020
Several strategies including physical activity and intermittent fasting (IF) were prescribed in the management of obesity and its associated complications. Ramadan diurnal intermittent fasting is a distinctive model of intermittent fasting; however, it is associated with decreased melatonin levels, disturbances in nocturnal sleep time, physical activity and energy intake. Exogenous melatonin (MLT) administration has been shown to improve circadian rhythm misalignment, postural balance and quality of life and to mitigate cholesterol metabolism, inflammatory markers and hyperglycemia as well as to promote sleep and improve its quality. This study aimed to examine to evaluate the safety and the efficiency of exogenous MLT administration combined with a concurrent training program performed throughout Ramadan diurnal intermittent fasting on body composition, biomarkers of metabolic heath and sleep quality, quality of life and postural balance in overweight/ obese sedentary women.
- Registry
- Pan Africa Clinical Trials Registry
- Trial ID
- PACTR202306614083752
- Type
- Non-Device Trial
Access comprehensive clinical trial information for PACTR202306614083752 through Pure Global AI's free database. This Phase 3 trial is sponsored by Research Laboratory molecular bases of human pathology LR19ES13 Faculty of medicine of Sfax and is currently Completed. The study focuses on Nutritional, Metabolic, Endocrine.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.